Literature DB >> 4201653

Treatment of central nervous system leukemia with intrathecal cytosine arabinoside.

P R Band, J F Holland, J Bernard, M Weil, M Walker, D Rall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4201653     DOI： 10.1002/1097-0142(197310)32:4<744::aid-cncr2820320402>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

Review 1.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

2.  Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors.

Authors:  D S Fulton; V A Levin; P H Gutin; M S Edwards; M L Seager; J Stewart; C B Wilson
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 3.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

Review 4.  The toxicity of cytarabine.

Authors:  J Stentoft
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

5.  Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.

Authors:  V A Levin; M Chamberlain; P Silver; L Rodriguez; M Prados
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment.

Authors:  L Vainionpää
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

Review 7.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

8.  Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.

Authors:  J C Scott-Moncrieff; T C Chan; M L Samuels; J R Cook; G L Coppoc; D B DeNicola; R C Richardson
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  Relationship between protein binding and extravascular drug concentrations of a water-soluble drug, cytosine arabinoside.

Authors:  M L Slevin; A Johnston; R C Woollard; E M Piall; T A Lister; P Turner
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.